Related Experiment Video
Updated: Aug 8, 2026

A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells
Published on: March 5, 2018
Complementation assays adapted for DNA repair-deficient keratinocytes
Mathilde Fréchet1, Valérie Bergoglio, Odile Chevallier-Lagente
1Laboratory of Genetic Instability and Cancer, Institute Gustave Roussy, Villejuif, France.
Abstract:
Genetic alterations affecting nucleotide excision repair, the most versatile DNA-repair mechanism responsible for removal of bulky DNA adducts including ultraviolet (UV) light-induced DNA lesions, may result in the rare, recessively inherited autosomal syndromes xeroderma pigmentosum (XP), Cockayne syndrome (CS), or trichothiodystrophy (TTD). Classical approaches such as somatic cell fusions or microinjection assays have formalized the genetic complexity of these related but clinically distinct syndromes, and contributed to the determination of seven, five, and three complementation groups for XP, CS, and TTD, respectively. XP patients are highly susceptible to photoinduced cutaneous cancers of epidermal origin. To better study the responses to UV irradiation of XP keratinocytes, and to objectively determine the extent to which cutaneous gene therapy may be realized, we set up experimental procedures adapted to ex vivo genetic complementation of keratinocytes from XP patients. We provide here detailed rationales and procedures for these approaches.
Insights
This study details ex vivo genetic complementation methods for xeroderma pigmentosum (XP) keratinocytes. These approaches aim to improve understanding of UV radiation responses and advance cutaneous gene therapy for XP patients.
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Nucleotide excision repair (NER) is crucial for removing bulky DNA adducts, including UV-induced lesions.
- Genetic defects in NER cause rare syndromes like xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD).
- XP patients exhibit extreme photosensitivity and high risk of skin cancers.
Purpose of the Study:
- To establish experimental procedures for ex vivo genetic complementation of XP keratinocytes.
- To facilitate the study of cellular responses to UV irradiation in XP.
- To assess the potential for cutaneous gene therapy in XP.
Main Methods:
- Development of specialized experimental procedures for ex vivo genetic complementation.
- Utilizing keratinocytes from XP patients for complementation assays.
- Focus on techniques applicable to studying UV responses and gene therapy.
Main Results:
- Detailed rationales and procedures for ex vivo genetic complementation are provided.
- The methods are designed for studying UV responses in XP keratinocytes.
- The study lays groundwork for assessing cutaneous gene therapy feasibility.
Conclusions:
- The developed ex vivo methods enable detailed study of UV responses in XP keratinocytes.
- These approaches are essential for advancing cutaneous gene therapy strategies for XP.
- This work contributes to understanding NER-related genetic disorders and their treatment.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Homologous Recombination
Long-patch Base Excision Repair
Fixing Double-strand Breaks
